Urban Health Today Editors

Urban Health Today

Certain patients with hematologic malignancies may be at greater risk for financial toxicity, according to a recent Australian <a href="https://pubmed.ncbi.nlm.nih.gov/34798569/">study</a>.Among patients seeking care through a publicly funded healthcare system, those who were of working age, those without private health insurances, and those that have been forced to retire early or were unemployed because of their diagnosis were more likely to experience financial toxicity.&ldquo;Out of pocket expenses constitute a significant contributor to financial toxicity and health-related debt, and even bankruptcy,&rdquo; study authors wrote. &ldquo;Most direct healthcare and hospital-related expenses in Australia are covered entirely or heavily subsidized by the Medicare Benefits Scheme. Nevertheless, out of pocket expenses borne by Australian patients were from medications, consultation fees and travel costs.&rdquo;The study surveyed 113 patients with leukemia, lymphoma, or multiple myeloma from two major metropolitan health services in Melbourne. The survey included a 12-item patient-reported outcome measure (COST) that included questions on satisfaction with finances and incomes, expenses and the ability to meet them, and level of control concerning finances and cancer care.In all, 42% of participants experienced some level of financial toxicity. Of the participants, 37% reported that they were employed in some capacity and 26% reported that they were unemployed or forced to retire because of their diagnosis.Most participants (71%) said they had used other means to cope financially including some or all of their savings (47%), borrowing money from friends or family (16%), or using credit card to cover costs (12%).About one in five participants had accumulated debt, which ranged from $350 to $40,000.A multivariate analysis showed that age older than 65 (P=0.007), higher income (P=.008), and not being forced into unemployment or retirement (P&lt;.0.001) were significantly associated with less financial toxicity. Not holding private health insurance was independently associated with worse COST scores.&ldquo;This study represents the first investigation of financial toxicity in haematology patients in Australia, who represent a particularly vulnerable group of individuals due to the often intensive and lengthy treatments that markedly impact everyday life,&rdquo; the researchers wrote. &ldquo;Further efforts are needed to unravel the complexity behind the observed financial burden to mitigate this burden by earlier intervention and to begin advocating meaningfully for patients.&rdquo;

Lou Portero

Climate Change Is Loading Rice With Arsenic

Public Health

FDA Authorizes First Prescription Digital Therapeutic for Migraine Prevention

Women's Neurology

How Vagus Nerve Signals Affect Eating Habits Across Socioeconomic Lines

Obesity

Latest News

Hematologic Malignancies Financially Burdensome in Australia

Cancer

Certain patients with hematologic malignancies may be at greater risk for financial toxicity, according to a recent ...

About Us

Editorial Policy

Contributors & Partners

Contact Us

eNewsletters

Work With Us

Advertising

Career Center

GU Oncology Now

Blood Cancers Today

Cancer Nursing Today

DocWire News

MashupMD

Food Allergy Roundtable Discussions

Allergy

Blood Cancers

— Multiple Myeloma

Breast Cancer

Colorectal Cancer

Pancreatic Cancer

Prostate Cancer

Diabetes

Gastroenterology

Heart Failure

Heart Disease Prevention

Heart Health

— Alzheimer’s Disease

Neurology

Autoimmune Disease

Infectious Diseases

Pediatrics

Sickle Cell Disease

Digital Health

Dermatology

Pulmonology

Video Insights

Workforce News

More

Gynecologic Cancer

Heart Disease in Women

Menopause

Reproductive Health

Women’s Neurology

Well Woman Today

Roundtables

Podcasts

Conferences

Viewpoints

Subscribe